Tondabayashi, Japan

Yoshihiro Oka


 


Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 138(Granted Patents)


Company Filing History:


Years Active: 2006-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Profile of Inventor Yoshihiro Oka

Introduction: Yoshihiro Oka, based in Tondabayashi, Japan, is an accomplished inventor with a focus on cancer immunology. With a total of 6 patents to his name, Oka's work significantly contributes to the field of therapeutic vaccines, particularly in relation to tumor antigens.

Latest Patents: Oka's latest patents are centered around tumor antigens based on products of the Wilms' tumor suppressor gene (WT1). One notable patent outlines a tumor antigen that consists of a product of the WT1 gene or a peptide made of 7-30 contiguous amino acids containing an anchor amino acid, which facilitates binding to major histocompatibility complex (MHC) class I. This patent also includes a vaccine that comprises this particular tumor antigen.

Career Highlights: Throughout his career, Yoshihiro Oka has shown a commitment to innovative research and development in the domain of cancer therapies. His dedication to exploring tumor suppressor genes has positioned him as a significant figure in the quest for effective cancer treatment solutions.

Collaborations: Oka has collaborated with notable figures and organizations in the field. He has worked alongside Haruo Sugiyama at the International Institute of Cancer Immunology, Inc., contributing to advancements in cancer immunology and therapeutic innovations.

Conclusion: Yoshihiro Oka's contributions to the field of cancer immunology, particularly through his patents related to WT1-derived tumor antigens, showcase his commitment to improving therapeutic approaches for cancer treatment. His collaborations and professional journey highlight the importance of innovative research in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…